Merck (MRK) Other Non-Current Assets (2009 - 2026)

Merck (MRK) has 16 years of Other Non-Current Assets data on file, last reported at $19.8 billion in Q1 2026.

• Other Non-Current Assets for Q1 2026 came in at $19.8 billion, up 18.12% year-over-year; the trailing twelve-month figure through Mar 2026 was $19.8 billion (up 18.12% YoY), and the FY2025 annual result was $18.8 billion, up 17.29% from the prior year.
• Other Non-Current Assets grew to $19.8 billion in Q1 2026 per MRK's latest filing, from $18.8 billion in the prior quarter.
• Over five years, Other Non-Current Assets peaked at $19.8 billion in Q1 2026 and troughed at $4.0 million in Q2 2022.
• A 5-year average of $12.8 billion and a median of $13.6 billion in 2024 frame the typical range for Other Non-Current Assets.
• The sharpest annual moves came in 2024 and 2025: Other Non-Current Assets jumped 18308.7% in 2024, then grew 17.29% in 2025.
• A 5-year view of Other Non-Current Assets shows it stood at $9.5 billion in 2022, then rose by 25.9% to $12.0 billion in 2023, then surged by 33.74% to $16.0 billion in 2024, then gained by 17.29% to $18.8 billion in 2025, then increased by 5.25% to $19.8 billion in 2026.
• Business Quant data shows MRK's Other Non-Current Assets at $19.8 billion in Q1 2026, $18.8 billion in Q4 2025, and $18.3 billion in Q3 2025.